Michael graduated from Johns Hopkins University in 2019 where he studied Neuroscience with a concentration in Systems. His research experience spans from the clinical psychiatric realm to pre-clinical trials for novel therapeutics to treat neurodegenerative disease. Recently, with the team at the Latin American Brain Health Institute (BrainLat), his efforts have taken on a translational capacity to assist in communicating neuroscience research internationally. He has served as a co-author for research that has been published in Brain and Cortex. Michael will be attending medical school in the US beginning in the fall of 2022.